ReviewDrug design, development and therapy2017

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy.

Alessandro Giunta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.